The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away

por Nagai, Yuya, Ambinder, Alexander J.
Publicado 2023

Potential targeting of FLT3 acute myeloid leukemia

por Ambinder, Alexander J., Levis, Mark
Publicado 2020

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia

por Ambinder, Alexander J., DeZern, Amy E.
Publicado 2022

Reply: Not All Inhaled Medicines Are Equal

por Rabin, Alexander S., Harlan, Emily A., Ambinder, Alexander J.
Publicado 2022

HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age

por Ambinder, Alexander, Jain, Tania, Tsai, Hua-Ling, Horowitz, Mary M., Jones, Richard J., Varadhan, Ravi
Publicado 2022

Exploring Risk Factors for Follicular Lymphoma

por Ambinder, Alexander J., Shenoy, Pareen J., Malik, Neha, Maggioncalda, Alison, Nastoupil, Loretta J., Flowers, Christopher R.
Publicado 2012

A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AML

por Ambinder, Alexander J., Norsworthy, Kelly, Hernandez, Daniela, Palau, Laura, Paun, Bogdan, Duffield, Amy, Chandraratna, Rosh, Sanders, Martin, Varadhan, Ravi, Jones, Richard J., Douglas Smith, B., Ghiaur, Gabriel
Publicado 2020